Tech Company Financing Transactions
Braveheart Bio Funding Round
Braveheart Bio, operating out of San Francisco, secured $185 million from Andreessen Horowitz, Enavate Sciences and Forbion Capital Partners.
Transaction Overview
Company Name
Announced On
11/5/2025
Transaction Type
Venture Equity
Amount
$185,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Francisco, CA Undisclosed
USA
San Francisco, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to transform the standard of care for hypertrophic cardiomyopathy and related conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Travis Murdoch
Browse more venture capital transactions:
Prev: 11/5/2025: Procurement Sciences AI venture capital transaction
Next: 11/5/2025: Mindsmith venture capital transaction
Share this article
About Our VC Transactions Data
We report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs